Dr. John Breeding presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are his remarks as promulgated in the world register of the meeting.
My call is John Breeding.I`ve been a Texas psychologist foralmost 30 years, and I`m a founding member of the Alliance for theAbolition of Ect in Texas.
